logo
Astronomers Find Hidden Volcano on Mars

Astronomers Find Hidden Volcano on Mars

Gizmodoa day ago

Mars's marred surface consists of craters, canyons, and mysterious formations that hint at a complex geological past. Scientists recently studied a tantalizing feature that could shed light on the planet's elusive history.
A mountain perched on the rim of Mars' Jezero Crater may actually be a volcano hiding in plain sight, according to a new study. This peak, called Jezero Mons, could offer new insight into the Red Planet's geologic history and the potential for ancient Martian life, the researchers say.
The findings, published in the journal Communications Earth & Environment in May, validate long-held suspicions that Jezero Mons is volcanic. Using data from three Mars orbiters and NASA's Perseverance rover, researchers found striking similarities between this mountain and explosive volcanoes previously identified on Mars and Earth.
'Jezero Crater is one of the best studied sites on Mars. If we are just now identifying a volcano here, imagine how many more could be on Mars,' said corresponding author James Wray, a professor of astrogeology and remote sensing at Georgia Tech, in a university statement. 'Volcanoes may be even more widespread across Mars than we thought.'
Wray has had a hunch that Jezero Mons is a volcano ever since he first laid eyes on it in 2007. 'I was looking at low-resolution photos of the area and noticed a mountain on the crater's rim,' he recalled in the statement. 'To me, it looked like a volcano, but it was difficult to get additional images.' At the time, scientists had only recently discovered the Jezero crater. Once scientists determined that it was likely an ancient lake bed, imaging efforts focused on its water history on the side opposite Jezero Mons.
Then, shortly after NASA's Perseverance rover landed in Jezero Crater in 2021, there was a break in the case. This rover gathers samples from the Martian surface to aid the search for past life, investigate the planet's climate and geology, and pave the way for human exploration of the Red Planet. Before long, data from Perseverance showed that the crater's floor was not sedimentary, as one would expect from a previously-flooded area. It was actually made of volcanic rock.
Wray wondered if this igneous rock could have come from Jezero Mons. He teamed up with lead author Sara Cuevas-Quiñones—a graduate student at Brown University who was working with Wray as part of a summer undergraduate research program at the time—to try to answer this question.
Wray, Cuevas-Quiñones, and their colleagues used a combination of data from the Mars Odyssey Orbiter, Mars Reconnaissance Orbiter, ExoMars Trace Gas Orbiter, and the Perseverance rover to 'puzzle this out,' Wray said. This wealth of data allowed the researchers to gain a deeper understanding of Jezero Mons' characteristics and compare it to other known volcanoes.
They found that the size and shape of this peak is similar to Martian volcanoes such as Zephyria and Apollinarus Tholi, as well as Mount Sidley in Antarctica. What's more, the researchers determined that the surface of Jezero Mons lacks impact craters and does not retain heat well—two signs that it may be covered in volcanic ash. Parts of the peak's northwestern flank also resembled edges of past lava flows that appear to reach the crater floor, which could explain why Perseverance found igneous rock there.
While this doesn't definitively prove that Jezero Mons is a volcano, it's some of the strongest evidence experts have so far. The findings mark an intriguing development in the search for life in Jezero Crater. A volcano located so close to this ancient lake might have generated hydrothermal activity—a source of energy that could have sustained past life.
Now, the researchers await the return of Perseverance's samples. Radioisotope dating can determine the precise age of the igneous rocks this rover collected, which could then be used to more accurately estimate Jezero Crater's age, according to the researchers. This would offer valuable insights into the geological history of the Red Planet.
Currently, NASA and its international partners have no solid plan to get this collection of rocks and dust back to Earth, but the agency is reviewing two Mars Sample Return (MSR) mission strategies with a goal of confirming the program in 2026. President Donald Trump's 2026 budget proposal, however, threatens to derail this program. If passed by Congress, the budget would terminate the MSR mission on the grounds that it is 'grossly over budget' and its goals can be achieved by human missions to Mars.
Wray is hopeful that he will get his hands on Perseverance's finds one way or another. 'If these samples are returned to Earth, we can do incredible, groundbreaking science with them,' he said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wanted: One NASA administrator
Wanted: One NASA administrator

Politico

time22 minutes ago

  • Politico

Wanted: One NASA administrator

Presented by WELCOME TO POLITICO PRO SPACE. Thanks to everyone who read our inaugural issue. The excitement continues this week with speculation on the next NASA administrator, Congressional Golden Dome talk, and a Florida push to snag NASA HQ. Who do you think the next NASA chief should be? Email me at sskove@ with tips, pitches and feedback, and find me on X at @samuelskove. And remember, we're offering this newsletter for free over the next few weeks. After that, it will be available only to POLITICO Pro subscribers. Read all about it here. The Spotlight Now that Donald Trump has pushed NASA administrator nominee Jared Isaacman through the airlock, the search is on to find the space agency's next boss. We spoke to 12 insiders and analysts about who could get the nod. The conclusion? They'll probably be retired military. Starship Troopers: At least three former two- and three-star generals with space ties could be in the mix, according to four industry officials, who like others were granted anonymity to discuss internal discussions. These include retired Space Force Maj. Gen. John Olson, Lt. Gen. John Shaw, and Air Force Lt. Gen. Steve Kwast. Olson served in the Space Force and in NASA. Shaw retired as deputy commander of Space Command in 2023. Kwast last served in the Air Force, but supporters pushed for him to lead the Space Force. (Notice a theme?) The industry buzz follows Trump's decision two weeks ago to rescind the nomination amid a feud between SpaceX founder and Isaacman ally Elon Musk. The president then made the head-turning announcement that Joint Chiefs Chair Gen. Dan Caine would weigh in on the search for the next administrator for NASA — an agency that is not part of the military. Starfleet: Retired service members rarely lead the civilian agency, whose employees are known more for studying the stars than working with weapons. It has some people worried. Other potential names floating in the stratosphere include NASA's Kevin Coggins and astronaut Mike Hopkins. Coggins is a former military official who serves as head of NASA's Space Communications and Navigation program. Hopkins is a former NASA astronaut who joined the Space Force — from space — and was the first astronaut for the U.S.'s newest military service. Former Rep. Mike Garcia (R-Calif.), who served on the House science subcommittee on space before Rep. George Whitesides (D-Calif.) unseated him this year, is yet another name circulating. Under Pressure: Both industry and lawmakers are eager to fill the role amid the White House's proposed budget cuts to NASA, competition with China to return to the moon, and Trump's plans to land astronauts on Mars. 'I had thought we would have [an administrator] by now,' Sen. Ted Cruz (R-Texas), chair of the Senate Commerce Committee, which oversees NASA, told my colleague Joe this week. 'I don't know what their timing is, but I hope that the White House moves swiftly.' Some senators were even willing to swallow their concerns about Isaacman, a billionaire who had no experience in government, to speed up the process. 'In this landscape of getting back [to the moon] quickly, usurping China, I was ready to give a technology entrepreneur a chance,' Sen. Maria Cantwell (D-Wash.), the ranking member of the Senate Commerce committee, told Joe. Twilight Zone: But industry officials were not aware of any candidates the White House had spoken with yet, a sign that no one has emerged as a frontrunner. A White House spokesperson declined to comment. The physics of the nomination process is also working against the space industry, thanks to a nomination backlog. Isaacman, who Trump tapped early relative to past NASA administrators, took six months to even get on the roster for a Senate vote. And we all know how that turned out. Galactic Government THE NASA HQ RACE TRAILS ALONG: States have spent months duking out who will snag NASA's headquarters once its Washington lease expires in 2028. Florida has just upped the ante. Much of the Florida congressional delegation sent a letter this week to Trump urging him to consider moving NASA headquarters to Florida's Space Coast. It looks remarkably like a letter sent in April by Texas Republicans making a similar plea to relocate NASA to Houston, aka the 'Space City.' All in? But only two of Florida's eight Democratic representatives stamped their approval. None of Texas' 12 Democrats did. 'Both states could rally their delegations if it was important,' an industry official said. Military GOLDEN GANG: The Trump administration may not know how it will build the president's 'Golden Dome' defense shield, but that hasn't stopped lawmakers from creating a caucus for it. Reps. Jeff Crank (R-Colo.) and Dale Strong (R-Ala.) launched the House Golden Dome caucus this week to complement its counterpart in the Senate, created in May by Sen. Tim Sheehy (R-Mont.). The highly nebulous plan involves placing interceptors in space to shoot down enemy missiles, a scheme that could cost more than $500 billion. Crank, a first time lawmaker, represents Colorado Springs, home of Space Command. Strong represents Huntsville, a space hub and possible future home of Space Command — over the opposition of his colleague. What Next: Trump announced in May that he had selected a design for the multi-layered system and tapped Space Force Gen. Michael Guetlein to lead development. But senators from both parties have said the plan is opaque, and the Pentagon canceled a major conference with industry on its plans just two weeks before the meetings were set to take place. The Reading Room House appropriators call for new Space Force acquisition pilot: Breaking Defense How Private Space Drives Space Force's Intel Delivery: Payload Space Force's first next-gen missile warning launch pushed to 2026: Defense News Voyager raises $383 million from upsized IPO: SpaceNews Event Horizon MONDAY: The Washington Space Business Roundtable holds a discussion on 2025 priorities for the FCC's Space Bureau. The Paris Air Show starts Monday and runs through Sunday. TUESDAY: The Lunar and Planetary Institute holds a virtual and in-person discussion of NASA's Europa Clipper mission. WEDNESDAY: The National Security Space Association hosts a classified forum on the Space Force's strategic plans. The Senate Armed Services Committee holds a hearing on the Defense Department's 2026 budget request. Photo of the Week

RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives

Yahoo

time43 minutes ago

  • Yahoo

RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives

Appointment Underscores RetinalGenix's Commitment to Integrating the Latest Advances in Genomics and Personalized Medicine into its Product Pipeline APOLLO BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN ('RetinalGenix' or the 'Company'), a pioneer in advanced retinal imaging and precision medicine, is pleased to announce the appointment of Dr. Taimour Langaee, MSPH, PhD, as its newest scientific advisor. Dr. Langaee will play a key role in advancing the Company's DNA GPS Pharmacogenetics initiatives, which are designed to optimize personalized treatment pathways for retinal and systemic diseases through cutting-edge genetic biomarkers and high-resolution retinal imaging. Dr. Langaee will oversee the genotyping/sequencing data processing, genetic and pharmacogenomics data analyses, and clinical genetic association studies between eye diseases and genetic variations. Dr. Langaee brings over two decades of extensive experience in pharmacogenomics/precision medicine, genetics/ epigenetics, genotyping/sequencing, preemptive clinical pharmacogenomics testing and implementation, molecular biology, microbiology/immunology, and infectious disease. He has led and collaborated on major research initiatives throughout his distinguished career, including the NIH Warfarin Study (COAG Trial), the Personalized Medicine Program, and multiple pharmacogenomic studies in cardiovascular, infectious, and neurological diseases. His work has directly influenced the implementation of pharmacogenetics in clinical practice, improving drug safety and efficacy for diverse patient populations. Dr. Langaee currently serves as Professor in the Department of Pharmacotherapeutics and Clinical Research at the University of South Florida's Taneja College of Pharmacy. He has taught several courses and has mentored and supervised many undergraduate students, PharmD candidates, graduate students, postdoctoral fellows, PGY2 Clinical PGx pharmacy residents, medical residents, and junior faculty members. Prior to this, Dr. Langaee was a leading figure at the University of Florida, where he directed the Center for Pharmacogenomics and Precision Medicine Genotyping Core Laboratory and contributed to numerous NIH-funded projects focused on the genetic determinants of drug response and personalized medicine. Jerry Katzman, MD, CEO of RetinalGenix Technologies, expressed his enthusiasm: 'We are thrilled to welcome Dr. Taimour Langaee to our advisory team. His extensive experience in pharmacogenetics and precision medicine will be invaluable as we expand our DNA GPS initiatives. Dr. Langaee's leadership in translating genetic insights into actionable clinical strategies aligns perfectly with our mission to deliver personalized, data-driven solutions for retinal and systemic health. His expertise will accelerate our efforts to bring the promise of pharmacogenomics to patients and providers worldwide.' Dr. Langaee's appointment underscores RetinalGenix's commitment to integrating the latest advances in genomics and personalized medicine into its product pipeline. As the Company continues its efforts to innovate at the intersection of retinal imaging, genetic analysis, and artificial intelligence, Dr. Langaee's guidance is expected to be instrumental in shaping the future of precision ophthalmology and beyond. The application of RetinalGenix's technologies goes beyond eye disease prevention. The retina is a window to systemic health, and advanced retinal imaging can reveal early signs of many chronic, pervasive diseases, including but not limited to diabetes, hypertension, cardiovascular disease, neurodegenerative diseases, and chronic kidney disease. RetinalGenix aims to flag early warning signs of these chronic conditions by integrating Pharmacogenetics, high-resolution retinal imaging, remote monitoring, and AI-powered analysis, prompting timely medical evaluation and intervention. This not only helps prevent blindness but also supports better overall health management, reducing the long-term costs associated with chronic disease complications. Timely Intervention and Personalized Care With remote monitoring, changes in retinal health can be identified promptly, enabling healthcare providers to intervene before irreversible vision loss occurs. When integrated with RetinalGenix DNA GPS PharmacogeneticsTM platform, the system intends to further personalize risk assessments and treatment plans based on an individual's genetic profile. This means that not only are problems detected earlier, but interventions might also be tailored to each patient's unique risk factors and likely response to treatment, potentially maximizing the effectiveness of preventive strategies. About RetinalGenixRetinalGenix is an ophthalmic research and development company seeking to revolutionize early disease detection and improve patient outcomes across multiple disease areas by integrating genetic screening, advanced imaging, and therapeutic development. Its proprietary High-Resolution Retinal Imaging and RetinalGenix DNA/RNA/GPS Pharmaco-Genetic Mapping™ technologies are designed to help prevent blindness by detecting initial physiological changes that could indicate future ocular and systemic diseases affecting neurodegenerative, cardiovascular, vascular, and metabolic systems, as well as diabetic conditions, Alzheimer's disease and Parkinson's disease. RetinalGenix is also developing therapeutic drugs for dry age-related macular degeneration (dry AMD) and Alzheimer's disease/dementia. Safe Harbor Statement This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words 'could,' 'believe,' 'anticipate,' 'intend,' 'estimate,' 'expect,' 'may,' 'continue,' 'predict,' 'potential,' 'project' and similar expressions that are intended to identify forward-looking statements and include statements regarding integrating the latest advances in genomics and personalized medicine into RetinalGenix's product pipeline, the expected contribution of Dr. Langaee, the Company's DNA GPS Pharmacogenetics initiatives optimizing personalized treatment pathways for retinal and systemic diseases through cutting-edge genetic biomarkers, and high-resolution retinal imaging, delivering personalized, data-driven solutions for retinal and systemic health, bringing the promise of pharmacogenomics to patients and providers worldwide, innovating at the intersection of retinal imaging, genetic analysis, and artificial intelligence, Dr. Langaee's guidance being instrumental in shaping the future of precision ophthalmology and beyond, advanced retinal imaging revealing early signs of many chronic, pervasive diseases, including but not limited to diabetes, hypertension, cardiovascular disease, neurodegenerative diseases, and chronic kidney disease, RetinalGenix flagging early warning signs of these chronic conditions by integrating Pharmacogenetics, high-resolution retinal imaging, remote monitoring, and AI-powered analysis, prompting timely medical evaluation and intervention, supporting better overall health management, reducing the long-term costs associated with chronic disease complications, changes in retinal health being identified promptly with remote monitoring, enabling healthcare providers to intervene before irreversible vision loss occurs, the system personalizing risk assessments and treatment plans based on an individual's genetic profile when integrated with RetinalGenix DNA GPS PharmacogeneticsTM platform, detecting problems earlier, tailoring interventions to each patient's unique risk factors and likely response to treatment, potentially maximizing the effectiveness of preventive strategies, revolutionizing early disease detection and improving patient outcomes across multiple disease areas by integrating genetic screening, advanced imaging, and therapeutic development, preventing blindness by detecting initial physiological changes that could indicate future ocular and systemic diseases affecting neurodegenerative, cardiovascular, vascular, and metabolic systems, as well as diabetic conditions, developing therapeutic drugs for dry age-related macular degeneration (dry AMD) and Alzheimer's disease/dementia. These forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict, that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company's ability to successfully complete research and further development and commercialization of Company imaging system or drug candidates, the timing, cost and uncertainty of obtaining regulatory approvals for the Company's imaging system or drug candidates, the Company's ability to protect its intellectual property, and the risk factors described in the Company's Annual Report on Form 10-K for the year the risk factors described in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and the Company's subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law. For further information, please contact:RetinalGenix Technologies and Investor Relationsir@ (800) 331-5446Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

This Chinese Spacecraft Is Traveling to One of Earth's Quasi-Moons
This Chinese Spacecraft Is Traveling to One of Earth's Quasi-Moons

WIRED

timean hour ago

  • WIRED

This Chinese Spacecraft Is Traveling to One of Earth's Quasi-Moons

Jun 13, 2025 5:00 AM The Tianwen-2 probe has sent a self-portrait as it heads toward one of the most enigmatic objects in our space neighborhood: the quasi-moon Kamo'oalewa. Tianwen 2's camera captured the solar wing in its fully deployed position. Photograph: China National Space Administration (CNSA) All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. The China National Space Administration has shared the first image from its Tianwen-2 probe, which is en route to Kamo'oalewa, a near-Earth asteroid. The image was captured by a camera onboard the probe, which is currently more than 3 million kilometers from Earth, and shows one of its wings with its solar panels deployed. It is also the first glimpse the CNSA has offered of its space probe, which launched on May 29 on a Long March 3B rocket from the Xichang Satellite Launch Center in Zeyuan Town, China. The design of Tianwen-2's panels is similar in appearance to those on Lucy, NASA's space probe that is exploring asteroids floating near Jupiter. These serve to meet the power demands required for the trip. Tianwen-2's mission is to land on the surface of Kamo'oalewa, collect samples, and return to Earth. The spacecraft is scheduled to land on the asteroid's surface in July 2026. Before then, it will spend several months studying Kamo'oalewa from a safe distance, to determine its sampling area, before proceeding with landing maneuvers, a particularly difficult task given the asteroid's low gravity. Once the samples have been collected, Tianwen-2 will travel back to Earth and send its samples down to the surface in a capsule, before then attempting to use Earth's gravity as a slingshot to head toward 311P/PanSTARRS, an unusual-looking asteroid beyond Mars that has some of the characteristics of a comet, including visible tails. Tianwen-2 is expected to conduct this mission until 2035. The Enigma of the Hawaiian Quasi-Moon Kamo'oalewa is one of Earth's seven known quasi-moons—objects that appear to be orbiting our planet, but which aren't actually gravitationally bound to Earth, and are actually asteroids circling the sun in an orbit similar to Earth's. Discovered in 2016 by astronomers at the Haleakala Observatory in Hawaii, Kamo'oalewa—whose name means 'oscillating celestial object' in Hawaiian—is located approximately 4.65 million kilometers from our planet, 12 times further away from Earth than the moon. Kamo'oalewa is estimated to be roughly 40 to 100 meters in diameter, has maintained its current orbit for 100 years, and will probably maintain it for 300 more. It's hoped that Tianwen-2 can solve the mystery of Kamo'oalewa's origin. One theory is that it's a chunk of rock that broke off from the moon millions of years ago. The sampling mission will help multiple scientific investigations into the composition of rocky celestial bodies, as well as aid scientists in the search for clues about the formation of the solar system. Observational evidence and modeling suggest that Kamo'oalewa has been orbiting the sun for millions of years, albeit with an unstable trajectory. A direct exploration of this asteroid could, in addition, expand knowledge about nearby celestial objects that might potentially pose a threat to Earth. This story originally appeared on WIRED en Español and has been translated from Spanish.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store